// App-Quantinova.ai

: 2 A Co-Crystal of Tramadol-Celecoxib in a 1:1 Molecular Ratio Produced Synergistic Antinociceptive Effects in a Postoperative Pain Model in Rats

Researchers

Presenter

  • Manuel Merlos

Principal Investigators

  • N/A

Medical Centers

  • Esteve Pharmaceuticals S.A., Barcelona, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Allodynia

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Tramadol/Acetaminophen

  • E58425

  • Acetaminophen

  • Celecoxib

  • ALT-210

  • Tramadol

  • Adolonta

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved